FDA 510(k)

AngioCloud Service

K-Number: K211713 · 2022-04-28

Decision Date2022-04-28

Product CodeLLZ

Advisory CommitteeRA

DecisionSubstantially Equivalent

Device Summary

AngioCloud Service is the device name listed in this FDA 510(k) record. The listed applicant is Angiocloud, LLC. It received FDA 510(k) clearance on 2022-04-28 under 510(k) number K211713. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AngioCloud Service?

AngioCloud Service is a medical device that received FDA 510(k) clearance on 2022-04-28. The listed applicant is Angiocloud, LLC. The 510(k) number is K211713.

When did AngioCloud Service receive FDA 510(k) clearance?

AngioCloud Service received FDA 510(k) clearance on 2022-04-28, under 510(k) number K211713.

Who is the listed applicant for AngioCloud Service?

The FDA 510(k) record lists Angiocloud, LLC as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AngioCloud Service?

The FDA product code for AngioCloud Service is LLZ.

Related Devices (Code: LLZ)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262449AdvaViewADVAHEALTH SOLUTIONS, LLC K261916NeuroQuant PETCortechs Labs, Inc.K260936RadioViewAINeurocareai, Inc. (Dba Savelife.Ai)K260588Cleerly LABSCleerly, Inc.K262462TheraSphere 360™ Y-90 Management PlatformBoston Scientific Corporation K262143ImageGrid StreamVueCandelis, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.